The following is a summary of “Benefit of adjuvant chemotherapy for resected stage I lung cancer with spread through air spaces: a systematic review and meta-analysis,” published in the April 2025 issue of the European Journal of Surgical Oncology by Du et al.
Read MoreCryoablation during lobectomy for lung cancer appears to be a safe and cost-effective strategy for easing postoperative pain, according to a study published in Pain and Therapy. “Cryoablation is performed by the surgeon...
Read More
Dr. Chao H. Huang explains his skepticism regarding a recent study that linked chronic pain to significantly higher lung cancer incidence and mortality rates.
Read More
Research shows results from a presurgical 6-minute walk test may predict cardiopulmonary risk...
Read More
Robotic-assisted thoracic surgery for lung cancer showed a short learning curve and strong outcomes, with 5-year survival rates comparable to open surgery.
Read More
TUESDAY, April 15, 2025 (HealthDay News) — Among individuals eligible for lung cancer...
Read MoreRecently, we found, using a cigarette carcinogen-induced lung cancer model, that soy protein isolate (SPI) was superior to casein in preventing lung cancer. In this study, we have attempted to identify the component(s) within...
Read MoreChronic postsurgical pain (CPSP) is being increasingly recognized as an important clinical problem. The purpose of this prospective multicenter study was to evaluate the prevalence and risk factors of CPSP at 3 months after...
Read MoreLung cancer, which claims 1.8 million lives annually, is still one of the leading causes of cancer-related deaths globally. Patients with lung cancer frequently have a bad prognosis because of late-stage detection, which...
Read More
Variations in certain genes, including XRCC1, CYP1A1, CYP1A2, SEMA3B, PADPRP, and mEPHX, impact lung cancer outcomes in Hispanic/Latino patients.
Read More
The following is a summary of “Mediating effects of coping strategies between symptom clusters and...
Read More
Patient and caregiver engagement interventions show significant potential for improving lung cancer outcomes, according to a systematic review in Lung Cancer.
Read More
TUESDAY, April 1, 2025 (HealthDay News) — More than 3.8 million U.S. lung cancer deaths were...
Read More
MONDAY, March 31, 2025 (HealthDay News) — Increased lung cancer screening uptake was seen...
Read More
Research assessing the nutritional status and impact of interventions for patients with lung cancer found that most exhibit an altered nutritional status.
Read More
TUESDAY, March 25, 2025 (HealthDay News) — For patients with resected stage IB-IIIA...
Read MoreLung cancer remains one of the most widespread and deadliest malignant tumors globally, with a particularly high mortality rate among all cancers. Recently, immunotherapy, particularly immune checkpoint inhibitors (ICIs), has...
Read MoreBACKGROUND Immunotherapy is now a well-established systemic anticancer treatment in both curative and palliative settings in oncology. Immune-related adverse events associated with pembrolizumab, a novel humanized therapeutic...
Read More
THURSDAY, March 20, 2025 (HealthDay News) — Screening adherence is associated with increased...
Read MoreRecently, long non-coding RNAs have gained an increasing amount of attention in treating lung cancer. However, a full understanding of how CCAT1 lncRNA works against proliferation is not yet available. Therefore, we assess the...
Read More
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.
